Pharma-focused B2B SaaS startup Leucine raises $7-M

Leucine, a Bengaluru- and New York, NY (USA)-based B2B software-as-a-service startup, has attracted USD 7 million Series A round led by US-based strategic investor Ecolab Inc with participation from VC investors Pravega Ventures and Axilor Ventures, apart from Techstars and angel investors. Leucine's Compliance Cloud platform functions as a "digital twin" of pharmaceutical manufacturing floors, offering real-time performance monitoring, compliance management, and actionable insights. The investment is expected to fast-track its development as well as the firm's artificial intelligence (AI)-driven tools tailored for the pharmaceutical manufacturing sector. The firm has announced the beta launch of Leucine10x, an AI framework intended to assist in pharmaceutical manufacturing processes.